学校放假了，那么现在你做什么来吸引你的孩子呢?6月29日，一些家长带着他们的家人来到宾夕法尼亚州的哈里斯堡，参加2016年宾夕法尼亚州宣传和获取日。一些年轻人已经是专业人士了，他们参加了之前的宣传活动和我们的Advocacy Summit in Washington, DC. For others it was a first time experience.
Continue readingYoung Advocates in Pennsylvania Speak Out
Tag Archives: biosimilars arthritis
Arthritis Foundation Collaborates with Providers at the State Level to Advocate for the Arthritis Community
Our advocacy team is incredibly active at the state level, leading the way to make sure that arthritis patients have access to critical medications. Our volunteer Advocates make asignificant impactand help achieve tangible results by sharing their stories and asking elected officials to support legislation that is important to them and their families. But beyond fighting for key legislative changes and being vocal in raising awareness and sharing stories that help put faces with arthritis, we also make strides for the arthritis community when we link the voices of patient with the provider community – as we have done recently and successfully in New York and Ohio.
Continue readingArthritis Foundation Collaborates with Providers at the State Level to Advocate for the Arthritis Community
Arizona Arthritis Advocates Achieve Biosimilar Substitution Victory!
With new, innovative arthritis medications coming to market, patients with arthritis may soon have access to potentially less expensive biosimilar medications (similar to biologics).
However, imagine that, without your knowledge, your pharmacy substituted the biologic medication prescribed by your doctor with a new interchangeable biosimilar. Residents of Arizona no longer have to worry because this week, Arizona Governor Doug Ducey signed House Bill 2310 (HB 2310) into law. HB 2310 allows pharmacists to substitute biologic medications with new, interchangeable and potentially less expensive biosimilar medications when they come to market. The bill also ensures patients and their physicians know when a substitution occurs, resulting in a complete and accurate patient medical record. And, if physicians do not want a substitution to occur, they can stipulate that the prescription be dispensed as written.
Continue readingArizona Arthritis Advocates Achieve Biosimilar Substitution Victory!
Advocates in Kentucky Get a Big Win for Biosimilar Substitution
Big news for our arthritis community in Kentucky! On April 13, 2016, Gov. Matt Bevin (R – KY) signed Senate Bill 134 into law. The law creates a pathway for the introduction and use of biosimilars into the mainstream marketplace. Biosimilar medications have the potential to provide safe and effective treatment to people with arthritis at a potentially lower cost than name-brand biologic medications.
The many letters, calls and visits made by Arthritis Foundation Advocates in Kentucky played a significant role in the passage of SB 134.
Continue readingAdvocates in Kentucky Get a Big Win for Biosimilar Substitution